The global cancer gene therapy market is anticipated to grow at a considerable CAGR of 23.1% during the forecast period. One of the key factors that are fueling the market is the growing competitiveness between the market players. With several key players in the market, companies are advancing, innovating, and launching new products to stay in the competition. For instance, in April 2022, Labcorp enhances cell and gene therapy development support through collaboration with X-cell biosciences. Labcorp and Xcellbio plan to collaborate on several projects aimed at increasing the safety and efficacy of cell and gene therapies (CGTs). This demonstrates Labcorp’s commitment to expanding its global, comprehensive suite of CGT capabilities, while also assisting pharmaceutical and biotechnology businesses in their attempts to accelerate medicinal development.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cancer-gene-therapy-market
Furthermore, in February 2022, BioMarin Pharmaceutical Inc. reported updates on its investigational gene therapy programs in clinical development. The company received additional requests from the Food and Drug Administration (FDA) for information required to resolve the clinical hold of the PHEARLESS Phase 1/2 study of BMN 307, which was issued in September 2021.
Another major factor contributing to the growth of the market is the increase in the adoption of various strategic initiatives such as mergers and acquisitions, partnerships, and others to stay competitive in the market. For instance, in December 2021, Novartis acquired Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness. This has increased better options available for end-users and increased the demand for various cancer gene therapies.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Therapy
- By End-Users
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Amgen, Inc., Biogen Inc., Bluebird Bio, Gilead Sciences, INC., Novartis, and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Cancer Gene Therapy Market Report Segment
By Therapy
- Gene Transfer Immunotherapy
- Oncolytic Virotherapy
- Gene Induced Immunotherapy
oDelivery of Cytokines Gene
oDelivery of Tumor Antigen Gene
By End-Users
- Hospitals
- Research Institutes
- Biopharma Companies
A full report of Cancer Gene Therapy Market is available at: https://www.omrglobal.com/industry-reports/cancer-gene-therapy-market
Cancer Gene Therapy Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Achilles Therapeutics Ltd.
- Adaptimmune Therapeutics Plc
- American Gene Technologies International Inc.
- Avrobio Inc.
- Beigene, Ltd.
- Bluebird Bio, Inc.
- Celgene Corporation
- Cell Medica Ltd.
- Formula Pharmaceuticals, Inc.
- Genprex, Inc.
- Genvec Inc.
- Glaxosmithkline PLC
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
